Biogenic amines and their metabolites are differentially affected in the Mecp2-deficient mouse brain.
about
MECP2 disorders: from the clinic to mice and backGABA and glutamate pathways are spatially and developmentally affected in the brain of Mecp2-deficient miceRett syndrome - biological pathways leading from MECP2 to disorder phenotypesDNA methylation map of mouse and human brain identifies target genes in Alzheimer's disease.Reward processing in autism: a thematic series.Effect of Sarizotan, a 5-HT1a and D2-like receptor agonist, on respiration in three mouse models of Rett syndromeAlterations in the cholinergic system of brain stem neurons in a mouse model of Rett syndromeTreatment of cardiac arrhythmias in a mouse model of Rett syndrome with Na+-channel-blocking antiepileptic drugs.Early intervention with psychostimulants or antidepressants to increase methyl-CpG-binding protein 2 (MeCP2) expressions: a potential therapy for Rett syndrome.Peripheral administration of brain-derived neurotrophic factor to Rett syndrome animal model: a possible approach for the treatment of Rett syndromeIncreasing brain serotonin corrects CO2 chemosensitivity in methyl-CpG-binding protein 2 (Mecp2)-deficient miceThe first mecp2-null zebrafish model shows altered motor behaviorsTagging methyl-CpG-binding domain proteins reveals different spatiotemporal expression and supports distinct functions.Breathing challenges in Rett syndrome: lessons learned from humans and animal models.When norepinephrine becomes a driver of breathing irregularities: how intermittent hypoxia fundamentally alters the modulatory response of the respiratory network.What Gene Mutations Affect Serotonin in Mice?Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings
P2860
Q26799760-D5F2230E-1BF4-4625-B783-CA5EF8BC7E18Q27314716-93BB552B-CE09-4BC3-8132-936DDC74E11EQ28025533-E921EA46-60A2-4BAA-8A33-209C1CAD4396Q30009564-6E05297A-EB2F-4AE7-A64B-8C6E2DFCB1DFQ30462673-D794437E-6726-45CE-B8D9-D2E38490568EQ33799538-39F75508-77C1-489D-9755-4A59E8982CBAQ34201031-616FEE51-FE4A-4986-85C8-A467F88242EAQ35237722-6492BE49-FA95-4E55-A641-6B308EB13F12Q36577177-DB090FFF-FD7C-4FFE-BD8C-2A766B1C9B20Q36577222-6AFA7651-98FD-43DD-964C-1E391AF06F3BQ36968088-83A003C0-64FC-4DE1-918C-22AF933FE956Q37017708-85136C1B-5BA3-453C-A0AA-B5E6DBCEE07AQ37055349-69AC08DC-0CD0-4809-9D48-9D13C8D54691Q37265909-83E735BA-6B54-48A9-9EEC-D3257E39F6C8Q37399949-72A215CC-2009-4EE5-9939-597E3F1ECB8AQ38434699-1C18EC7D-EBB4-4839-AC53-57AD3A3B6A82Q59292055-C835D835-3AE0-46E4-B851-7977DF6B2F02
P2860
Biogenic amines and their metabolites are differentially affected in the Mecp2-deficient mouse brain.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Biogenic amines and their meta ...... e Mecp2-deficient mouse brain.
@ast
Biogenic amines and their meta ...... e Mecp2-deficient mouse brain.
@en
type
label
Biogenic amines and their meta ...... e Mecp2-deficient mouse brain.
@ast
Biogenic amines and their meta ...... e Mecp2-deficient mouse brain.
@en
prefLabel
Biogenic amines and their meta ...... e Mecp2-deficient mouse brain.
@ast
Biogenic amines and their meta ...... e Mecp2-deficient mouse brain.
@en
P2093
P2860
P356
P1433
P1476
Biogenic amines and their meta ...... e Mecp2-deficient mouse brain.
@en
P2093
Adeline Ghata
Jean-Christophe Roux
Laurent Villard
Nicolas Panayotis
P2860
P2888
P356
10.1186/1471-2202-12-47
P577
2011-05-24T00:00:00Z
P5875
P6179
1052478930